{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:34:38Z","timestamp":1773815678864,"version":"3.50.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects fertility and metabolism. Obesity, present in a significant proportion of PCOS patients, exacerbates insulin resistance (IR) and worsens reproductive outcomes. This study explores the effects of a 12-week 5:2 intermittent fasting diet with meal replacement (MR) on body weight, metabolic, and endocrine markers in obese women with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A non-randomized, single-arm interventional study was conducted with 90 obese women diagnosed with PCOS. Participants were assigned to three groups: 5:2 intermittent fasting with MR, non-meal replacement intermittent fasting, and no intervention. To reduce potential confounding, the study utilized Propensity Score Matching (PSM) to match baseline characteristics such as age, body mass index (BMI), and metabolic markers. Primary outcomes included changes in body weight, BMI, waist circumference, fasting insulin, glucose levels, and reproductive hormone markers. Menstrual regularity and ovulation frequency were also assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The intervention group (5:2 intermittent fasting with MR) showed significant reductions in body weight (from 77.15 kg to 69.1 kg, P &amp;lt; 0.001), waist circumference, and BMI. Insulin resistance (HOMA-IR) decreased significantly (P = 0.008), and a reduction in 2-hour glucose levels (P = 0.025) was observed. Although metabolic markers improved, reproductive hormones (follicle-stimulating hormone [FSH], luteinizing hormone [LH], estradiol, progesterone) did not show significant changes. However, menstrual regularity improved in 80% of participants, and 50% showed improved ovulation frequency. The non-meal replacement intermittent fasting group also showed improvements, but to a lesser extent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The 5:2 intermittent fasting diet with MR significantly reduces body weight, improves insulin sensitivity, and enhances metabolic markers in obese women with PCOS. Although reproductive hormone levels did not significantly change, menstrual and ovulatory function improved. Future studies with larger sample sizes and longer follow-up are needed to explore the long-term effects of intermittent fasting on reproductive health in PCOS patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1758805","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:38:46Z","timestamp":1773812326000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of a 5:2 intermittent fasting diet on obese patients with polycystic ovary syndrome"],"prefix":"10.3389","volume":"17","author":[{"given":"Wencheng","family":"An","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital","place":["Haidian, Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital","place":["Haidian, Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Peking University Third Hospital","place":["Haidian, Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital","place":["Haidian, Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital","place":["Haidian, Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"An","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital","place":["Haidian, Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital","place":["Haidian, Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital","place":["Haidian, Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital","place":["Haidian, Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixian","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Beijing Haidian Hospital, Beijing Haidian Section of Peking University Third Hospital","place":["Haidian, Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13477","article-title":"The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis","volume":"88","author":"Behboudi-Gandevani","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","article-title":"Polycystic ovary syndrome","volume":"10","author":"Stener-Victorin","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12762","article-title":"Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression","volume":"20","author":"Lim","year":"2019","journal-title":"Obes Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.2021.4788","article-title":"Diagnosis and management of infertility: A review","volume":"326","author":"Carson","year":"2021","journal-title":"Jama"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.23769","article-title":"Diagnosis and treatment of polycystic ovary syndrome","volume":"327","author":"Huddleston","year":"2022","journal-title":"Jama"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmz013","article-title":"The effect of physical activity on reproductive health outcomes in young women: a systematic review and meta-analysis","volume":"25","author":"Mena","year":"2019","journal-title":"Hum Reprod Update"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.11124\/JBISRIR-2016-003248","article-title":"Intermittent fasting interventions for treatment of overweight and obesity in adults: a systematic review and meta-analysis","volume":"16","author":"Harris","year":"2018","journal-title":"JBI Database System Rev Implement Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13855","article-title":"Longer-term effects of intermittent fasting on body composition and cardiometabolic health in adults with overweight and obesity: A systematic review and meta-analysis","volume":"26","author":"Khalafi","year":"2025","journal-title":"Obes Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100341","DOI":"10.1016\/j.metop.2024.100341","article-title":"The impact of intermittent fasting on fertility: A focus on polycystic ovary syndrome and reproductive outcomes in Women-A systematic review","volume":"25","author":"Velissariou","year":"2025","journal-title":"Metabol Open"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s13668-024-00569-1","article-title":"Effects of intermittent fasting on female reproductive function: A review of animal and human studies","volume":"13","author":"Mao","year":"2024","journal-title":"Curr Nutr Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1362226","article-title":"Effect of calorie restriction and intermittent fasting on glucose homeostasis, lipid profile, inflammatory, and hormonal markers in patients with polycystic ovary syndrome: a systematic review","volume":"11","author":"Kalsekar","year":"2024","journal-title":"Front Nutr"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2014.214","article-title":"Fasting for weight loss: an effective strategy or latest dieting trend","volume":"39","author":"Johnstone","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-010-0103-9","article-title":"Weight management using a meal replacement strategy in type 2 diabetes","volume":"10","author":"Hamdy","year":"2010","journal-title":"Curr Diabetes Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0874","article-title":"Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial","volume":"34","author":"Unick","year":"2011","journal-title":"Diabetes Care"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jand.2015.02.018","article-title":"Intermittent fasting and human metabolic health","volume":"115","author":"Patterson","year":"2015","journal-title":"J Acad Nutr Diet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"CLINICAL PRACTICE. Polycystic ovary syndrome","volume":"375","author":"Mccartney","year":"2016","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2014.102","article-title":"The management of patients with polycystic ovary syndrome","volume":"10","author":"Jayasena","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0756","article-title":"Effect of intermittent compared with continuous energy restricted diet on glycemic control in patients with type 2 diabetes: A randomized noninferiority trial","volume":"1","author":"Carter","year":"2018","journal-title":"JAMA Netw Open"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0048","article-title":"Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial","volume":"30","author":"Pi-Sunyer","year":"2007","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114510003788","article-title":"Improvements in LDL particle size and distribution by short-term alternate day modified fasting in obese adults","volume":"105","author":"Varady","year":"2011","journal-title":"Br J Nutr"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2014.05.013","article-title":"Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention: a review of human findings","volume":"164","author":"Barnosky","year":"2014","journal-title":"Transl Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.3390\/nu15183872","article-title":"The effect of a very-low-calorie diet (VLCD) vs. a moderate energy deficit diet in obese women with polycystic ovary syndrome (PCOS)-A randomised controlled trial","volume":"15","author":"Deshmukh","year":"2023","journal-title":"Nutrients"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.3390\/nu17152436","article-title":"Effect of intermittent fasting on anthropometric measurements, metabolic profile, and hormones in women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"17","author":"Ranneh","year":"2025","journal-title":"Nutrients"},{"key":"B26","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-14-0253","article-title":"The polycystic ovary syndrome: a position statement from the European Society of Endocrinology","volume":"171","author":"Conway","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12967-021-02817-2","article-title":"Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome","volume":"19","author":"Li","year":"2021","journal-title":"J Transl Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/jrms.jrms_280_24","article-title":"Comparison of the impact of intermittent fasting diet alone or in conjunction with probiotic supplementation versus calorie-restricted diet on inflammatory, oxidative stress, and antioxidant capacity biomarkers in women with polycystic ovary syndrome: A randomized placebo-controlled trial","volume":"30","author":"Talebi","year":"2025","journal-title":"J Res Med Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/oby.23568","article-title":"A meta-analysis comparing the effectiveness of alternate day fasting, the 5:2 diet, and time-restricted eating for weight loss","author":"Elortegui Pascual","year":"2023","journal-title":"Obes (Silver Spring)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1758805\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:38:47Z","timestamp":1773812327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1758805\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":29,"alternative-id":["10.3389\/fendo.2026.1758805"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1758805","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"article-number":"1758805"}}